Хуудас 1 -аас 200 үр дүн
OBJECTIVE
The aim of this study was to determine whether a rapid, fingerstick β-hydroxybutyrate (β-OHB) test predicts ketonuria in pregnant women with nausea and vomiting.
METHODS
A convenience sample of 82 pregnant women who presented to the Barnes-Jewish Hospital emergency department (ED) with
OBJECTIVE
This paper is a report of a study to examine the effect of Nei-Guan point acupressure on nausea, vomiting and ketonuria levels in women diagnosed with hyperemesis gravidarum.
BACKGROUND
Previous studies have shown that acupressure application on the Nei-Guan point is effective in relieving
OBJECTIVE
To alert physicians to the possibility of pulmonary edema as a complication of diabetic ketoacidosis.
METHODS
We report a case of adult respiratory distress syndrome after resuscitative efforts to compensate the first episode of diabetic ketoacidosis in a previously healthy young
Diabetes is the fifth leading cause of death worldwide. Diabetic ketoacidosis (DKA) is a life-threatening acute complication of diabetes. The aim of this study is to investigate the clinical and biochemical characteristics of DKA among 400 patients admitted to hospital, most of whom had type 1
Diabetes ketoacidosis (DKA) is largely associated with type 1 diabetes and has hyperglycaemia as a cardinal feature. We discuss the case of a 42-year-old man, a patient with type 2 diabetes, who presented to the emergency room, with nausea, vomiting and abdominal pain. He had recently changed his
Ketoacidosis is a severe metabolic complication mainly reported in diabetic patients. Therapeutic fasting is a millennial worldwide practice, believed to improve a large panel of health conditions, but its efficiency and safety profile have not yet been established. We report here a Euglycemic Diabetic Ketoacidosis is an uncommon occurrence. It is caused by an interaction of existing and worsening acidosis due to nausea and vomiting by a precipitating illness. In this case, a Type I Diabetic patient initially presented with Diabetic Ketoacidosis (DKA) that eventually evolved
A 54-year-old white female with hypothyroidism presented with abdominal pain, nausea, vomiting, and diarrhea. She was found to have diabetic ketoacidosis (DKA) and admitted to our hospital for treatment. Laboratory workup revealed positive antiglutamic acid decarboxylase antibodies and subsequently
End-tidal carbon dioxide (EtCO2) is a non-invasive method giving information about the perfusion, ventilation, and metabolic condition of patients. The correlation was studied here between the metabolic (pH, bicarbonate) values and EtCO2 during the treatment of diabetic ketoacidosis In this report, the authors describe a unique presentation of ventriculomegaly in the setting of diabetic ketoacidosis (DKA). A 15-year-old male, with a history of shunt placement for hydrocephalus and repair of a myelomeningocele, presented to the emergency room with DKA and was found to have
BACKGROUND
Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemia (HH) remain life-threatening complications of diabetes mellitus. Herein, we evaluated a standardized protocol for the therapy of acute hyperglycemic crises.
METHODS
Retrospective study of patients treated in a medical intensive
Diabetic ketoacidosis and hyperosmolar hyperglycemic state are 2 potentially life-threatening presentations of feline diabetes mellitus. Presentations range from mildly anorexic cats with diabetic ketoacidosis to comatose cats with diabetic ketoacidosis or hyperosmolar hyperglycemic state. Such
Acute pancreatitis and diabetic ketoacidosis are unusual adverse events following chemotherapy based on L-asparaginase and prednisone as support treatment for acute lymphoblastic leukemia. We present the case of a 16-year-old Hispanic male patient, in remission induction therapy for acute
OBJECTIVE
Diabetic ketoacidosis (DKA), a well-known complication of diabetes mellitus, is associated with severe diffuse cerebral edema leading to brain herniation and death. Survival from an episode of symptomatic cerebral edema has been associated with debilitating neurological sequelae, including
Canagliflozin is a novel sodium-glucose cotransporter-2 (SGLT-2) inhibitor approved for the management of diabetes. We report the presentation and management of two cases of canagliflozin associated diabetic ketoacidosis (DKA) and discuss the mechanism of canagliflozin associated DKA. Patient 1, a